Esther Cho, SVP and General Counsel at Keros Therapeutics ($KROS), made one open market sale of company shares in the last year, totaling about $78,000. Her most recent sale occurred on February 18, 2026. This activity ranks her 9,919th among 11,678 insiders in our database by sale value, well below the average of $8.6 million across about 6.4 transactions per insider. She reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 24, 2026 | Keros Therapeutics, Inc. | $KROS | Cho Esther | Chief Legal Officer | A | Employee Stock Option (Right to Buy) | 80000 | $0.00 | 80,000.0000 | 41,202,371 | 9999.99% | 0.19% |
| Feb. 24, 2026 | Keros Therapeutics, Inc. | $KROS | Cho Esther | Chief Legal Officer | A | Employee Stock Option (Right to Buy) | 80000 | $0.00 | 80,000.0000 | 41,202,371 | 9999.99% | 0.19% |
| Feb. 18, 2026 | Keros Therapeutics, Inc. | $KROS | Cho Esther | SVP, General Counsel | S | Common Stock | 4745 | $16.35 | 39,755.0000 | 41,202,371 | 10.66% | 0.01% |